Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Outcomes of a routine invasive strategy in elderly patients with non-ST-segment elevation myocardial infarction from 2005 to 2014

results from the PL-ACS registry

Piątek, Łukasza,b; Wilczek, Krzysztofd; Janion-Sadowska, Agnieszkab; Gierlotka, Mareke; Gąsior, Mariuszd; Sadowski, Marcina,c

doi: 10.1097/MCA.0000000000000708
Original research: PDF Only
Buy
PAP

Background Elderly patients (≥75 years old) with non-ST-segment elevation myocardial infarction (NSTEMI) represent a large subgroup of all cases. They are rarely included in randomized trials because of comorbidities and concerns about complications. Furthermore, invasive treatments are used less frequently in this patient group. The aim of this study was to analyze trends in invasive procedures and outcomes in elderly patients with NSTEMI from 2005 to 2014.

Patients and methods We analyzed 68 978 elderly patients with NSTEMI enrolled in the prospective, nationwide Polish Registry of Acute Coronary Syndromes from 2005 to 2014.

Results Elderly patients accounted for 34.9% of all patients with NSTEMI. There was an increase in the rate of coronary angiography from 19.1% in 2005–2007 to 83.5% in 2012–2014 among women (P<0.05) and from 26.0 to 87.5% among men (P<0.05). Simultaneously, there was an increase in percutaneous coronary intervention usage from 12.9% in 2005–2007 to 56.3% in 2012–2014 among women (P<0.05) and from 17.6 to 60.5% among men (P<0.05). On comparing the periods of 2005–2007 and 2012–2014, in-hospital mortality decreased considerably from 9.6 to 5.3% among women (P<0.05) and from 9.1 to 4.7% among men (P<0.05). In the same time period, the 12-month mortality ratio decreased: from 30.5 to 22.0% among women (P<0.05) and from 32.0 to 22.8% among men (P<0.05). In multivariate analysis, age was one of the most important factors associated with poorer outcome. With each increased decade of life, the outcomes worsened – the relative risk of mortality was 1.63 [95% confidence interval (CI): 1.59–1.68] for the in-hospital prognosis and 1.57 (95% CI: 1.55–1.59) for the 12-month prognosis. Invasive treatment strategy was the strongest factor associated with improved outcome, with a relative risk of 0.31 (95% CI: 0.29–0.33) for in-hospital mortality and 0.51 (95% CI: 0.49–0.52) for 12-month mortality, respectively.

Conclusion Patients with NSTEMI benefit considerably from invasive procedures independent of age. In-hospital as well as 12-month outcomes in elderly patients improved markedly in the last decade as a result of the wide implementation of an invasive treatment strategy.

aThe Faculty of Medicine and Health Sciences, The Jan Kochanowski University

b2nd Department of Cardiology

cDepartment of Interventional Cardiology, Świętokrzyskie Cardiology Centre, Kielce

d3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze

eDepartment of Cardiology, University Hospital in Opole, Faculty of Natural Sciences and Technology, University of Opole, Opole, Poland

Correspondenc to Łukasz Piątek, MD, 2nd Department of Cardiology, Świętokrzyskie Cardiology Centre, 45 Grunwaldzka St, 25-715 Kielce, Poland Tel: +48 504 590 245; fax: +48 41 367 1456; e-mail: piatas22@op.pl

Received August 10, 2018

Received in revised form December 7, 2018

Accepted December 21, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.